secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2026-07-23T20:51:27+00:00
Accession:  0001628280-26-049426
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics amends CEO Steve Ledger's employment agreement with enhanced severance and equity acceleration
--------------------------------------------------------------------------------

- Base salary of $500,000 unchanged; target annual bonus set at 50% of base salary.
- Non-CIC termination severance: 12 months base salary plus pro-rated target bonus, 12 months COBRA.
- CIC termination severance: 1.5x base salary plus 1.5x target bonus plus pro-rated bonus, 18 months COBRA.
- Full acceleration of unvested time-based equity awards upon a Qualifying CIC Termination.
- Non-compete covenant for 2 years; non-solicit and no-hire for 18 months post-termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000162828026049426/0001628280-26-049426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000162828026049426/ser-20260719.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-049426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer